Critical Care Pharmacy Clinical Sessions (Cert # L249213)
ACPE Numbers: Various – see listing below
Content Release Date: December 18, 2024
Expiration Date: December 16, 2025
Activity Type: Application-based
CE Credits: 4.5 hours contact (ACPE and BPS)
Activity Fee: $155 (ASHP member); $260 (non-member)
Activity Overview
This Clinical Sessions package is intended for board-certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in critical care.
The Critical Care Pharmacy Clinical Sessions Recertification Package consists of 3 activities (see table below) and provides up to 4.5 contact hours of continuing pharmacy education and/or recertification credit.
These activities are part of the ASHP and ACCP professional development program for BCCCP recertification approved by BPS. For pharmacists who maintain more than one certification, each of the activities are approved for multiple specialties (see table below).
These activities were presented as part of the 2024 ACCP Annual Meeting and 2024 ASHP Midyear Clinical Meeting. Learners who claimed ACPE credit for these activities as part of that meeting should not claim ACPE credit again.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education.
Target Audience
These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:
- New antibiotics for gram-negative bacterial infections
- Management of acetaminophen toxicity
- Anticoagulation reversal strategies
Recertification Credit
Board-certified pharmacists are eligible to receive up to 4.5 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline.
ASHP provides an opportunity for remediation. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.
ACCP and ASHP are approved by BPS as a provider for the recertification of BCCCP.
Learning Activity |
Passing Score |
Credit Information |
New and Pipeline Antibiotics for Gram-Negative Bacterial Infections |
70% |
1.5 Contact Hours BPS: BCCCP, BCPPS |
Nick-NAC APAP Whack |
76% |
1.5 Contact Hours BPS: BCEMP, BCCCP, BCPPS |
To Reverse or Not to Reverse: Clinical Considerations and Strategies for Anticoagulation Reversal |
80% |
1.5 Contact Hours BPS: BCCCP,BCEMP |
Learning Objectives
New and Pipeline Antibiotics for Gram-Negative Bacterial Infections
ACPE: 0204-9999-24-254-H01-P
- Compare the spectrum of activity, pharmacokinetics, and pharmacodynamic properties of newly approved antibiotics for the treatment of difficult-to-treat gram-negative bacterial infections in adult and pediatric populations.
- Interpret biomedical literature including study design and methodology, significance of reported data and conclusions, limitations, and applicability of study results to adult and pediatric patients with difficult-to-treat gram-negative bacterial infections.
- Given a description of an adult or pediatric patient with a difficult-to-treat gram-negative infection, design an antibiotic regimen that reflects the application of the best available evidence and current guidelines.
This activity is approved for Board-Certified Pediatric Pharmacy Specialist (BCPPS) and Board-Certified Critical Care Pharmacist (BCCCP) recertification credit.
Nick-NAC APAP Whack
ACPE: 0204-9999-24-278-H01-P
- Evaluate current guideline recommendations for patients presenting with acetaminophen toxicity.
- Develop an effective treatment regimen for the management of a patient presenting with acetaminophen toxicity.
- Develop monitoring strategies for the different medications utilized to treat acetaminophen toxicity.
- Design an effective treatment plan for patients requiring adjunctive treatment options for acetaminophen toxicity.
This activity is approved for Board-Certified Pediatric Pharmacy Specialist (BCPPS), Board-Certified Crtical Care Pharmacist (BCCCP), and Board-Certified Emergency Medicine Pharmacist (BCEMP) recertification credit.
To Reverse or Not to Reverse: Clinical Considerations and Strategies for Anticoagulation Reversal
ACPE: 0204-9999-24-327-H01-P
- Summarize available anticoagulant reversal agents and literature surrounding their use.
- Evaluate the main pillars of anticoagulation reversal to assess when reversal is clinically appropriate.
- Develop a comprehensive anticoagulation reversal plan with consideration of patient-specific factors.
This activity is approved for Board-Certified Critical Care Pharmacist (BCCCP) and Board-Certified Emergency Medicine Pharmacist (BCEMP) recertification credit.
Faculty
Dareen M. Kanaan, PharmD, MPH, BCCP
Clinical Pharmacy Specialist III
Brigham and Women's Hospital
Kalen Manasco, PharmD, BCPS, BCPPS, FCCP, FPPAG
Clinical Professor
University of Florida College of Pharmacy
Megan Musselman, PharmD, MS, BCEMP, BCCCP, BCPS, DPLA, FASHP, FCCP
EM Clinical Pharmacy Specialist/Team Lead, PGY2 EM Pharmacy RPD
North Kansas City Hospital
Lena Tran, PharmD, BCCCP
Clinical Pharmacy Specialist, PGY1 Residency Program Director
AdventHealth Central Florida
Trang D. Trinh, PharmD, MPH, BCPS, BCIDP
Associate Professor of Clinical Pharmacy
University of California, San Francisco School of Pharmacy
David E. Zimmerman, PharmD, BCCCP, BCEMP, FASHP
Associate Professor of Pharmacy, EM Pharmacist
Duquesne University
Reviewers
Sue Dombrowski, MS, RPh
Editors
Michelle Abalos, PharmD
Kristi Hofer, PharmD
Amy Holmes, PharmD, BCPPS
Anna Jackson, PharmD, BCPS
Content Matter Experts
Heather Draper, PharmD, BCPS, BCEMP
Peter Johnson, PharmD, BCPPS, BCPS, FCCM, FPPAG
Paul Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS
Jennifer Thackray, PharmD, BCPPS, BCPS
Heather Torbic, PharmD, BCPS, BCCCP, FCCM
David E. Zimmerman, PharmD, BCCCP, BCEMP, FASHP
Field Testers
Sam Abid, PharmD, BCPS, BCEMP
Christopher Andrews, PharmD, BCEMP
Emily Ankney, PharmD, BCCCP, BCEMP
Renzio Apostol, BCPPS
Ashley Asbell, PharmD, BCCCP
Jessica Barajas, PharmD, BCEMP
Lauren Behl, PharmD, BCPPS
Sarah Belz, PharmD, BCPPS
Gideon Berdahl, PharmD, BCCCP
Michelle Blesso, PharmD, BCPS, BCEMP
Heather Blue, PharmD, BCPS, BCEMP
Jessica Boben, PharmD, BCPS, BCEMP
Rebecca Bosworth, PharmD, BCPPS
Kara Boyko Frandson, PharmD, BCPS, BCEMP
Laura Branum, PharmD, BCEMP
Jeff Bruno, PharmD, BCPS, BCNSP, BCCCP, FCCM
Kymberly Buzzeo, PharmD, MBA, BCPPS
Teresa Calamas, PharmD, BCEMP
Anna Capulong, PharmD, BCPS, BCEMP
Laura Carson, PharmD BCCCP BCEMP
Jennifer Catlin, PharmD, BCPS, BCCCP
Allison Clarke, PharmD, BCEMP, BCPS
Enoch Claude, PharmD, BCPS, BCCCP
Bailey Constantine, PharmD, BCPS, BCCCP, BCEMP
Phillip Cook, Pharm.D, BCPS, BCCCP, BCEMP
John Day, PharmD, BCPS, BCPPS
Emily Dyer, PharmD, BCPS, BCEMP
Kallie Erickson, PharmD, BCPPS
Leanna Garner, PharmD
Haden Geiger, PharmD, BCEMP
Alexanna Gluck, PharmD, BCPPS
Nicole Goosby, PharmD, BCPPS
Thomas Gregory, PharmD, BCPS, BCEMP
Brianne Hansen, PharmD, BCPS, BCCCP
McKenzie Harris, PharmD, BCPPS
Shannon Hasara, PharmD, BCCCP, BCEMP
Jessica Hasty, PharmD, BCCCP, BCEMP
Pui Man Ho, PharmD, BCPPS
Jessica Hu, PharmD, BCCCP
Lindsay Jacobs, PharmD, MPH, BCCCP, BCEMP
Abigail Jansen, PharmD, BCEMP
Weina Jiang, PharmD,BCPS,BCEMP
Manar Kandil, PharmD, MS, BCPS, BCCCP, BCEMP
Marcus Kaplan, PharmD, BCPS, BCEMP
Ksenya Kavva, PharmD, BCPPS
Jennifer Kim, PharmD, BCPPS
Lydia Kouletsis, PharmD, BCPPS
Miranda Lackie, PharmD, BCCCP
Michael Lake, PharmD, BCPS, BCEMP
John Littler, PharmD, BCPS, BCEMP
Jessica Ma, PharmD, BCPPS
Amanda Marrack, PharmD, BCPPS
Amy Meeker, PharmD, BCPPS
Matthew Morrison, PharmD, BCPS, BCEMP
Zarema Muratova, BS Pharm, BCPPS
Luke Neff, PharmD, BCEMP
Liz Palmer, PharmD, BCPS, BCEMP, BCCCP
Duyen-Anh Pham, PharmD, BCPS, BCPPS
Melissa Philipson, Pharm.D, BCEMP
Cody Pitts, PharmD, BCPS, BCEMP
Brooke Raymond, PharmD, BCPS, BCPPS
Morgan Ridout, PharmD, MBA, BCCCP
Christina Riley, PharmD, BCEMP, BCCCP
Alyssa Robertson, PharmD, BCPS, BCCCP, BCEMP
Amy Rodriguez, PharmD, BCPS, BCCCP
Cathrine Roels, PharmD, BCCCP, BCEMP
Kyllie Ryan-Hummel, PharmD, BCCCP
Erin Sadek, PharmD, BCEMP
Airka Sanchez, PharmD
Ravipal Singh, PharmD, BCEMP, BCCCP
Heather Smith, PharmD, BCPS, BCEMP
Katherine Stein, PharmD, BCPPS
Sarah Stepanek, PharmD, BCEMP
Amanda Vanderwerf, PharmD, BCEMP
Kassandra Vettleson, PharmD, BCPS, BCPPS
Michelle Wang Nesdill, PharmD, BCPS, BCEMP
Jontae Warren, PharmD, BCPPS
Nicole Wilcox, PharmD, BCPPS
Siu Yan Amy Yeung, PharmD, BCCCP
Abigail Zeiner, PharmD, BCPS, BCEMP
Disclosures
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Methods and CE Requirements
Activities which can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Development
ACCP and ASHP collaborate on critical care pharmacy activities.